Wednesday, February 19, 2020 8:47:37 AM
Fort Lauderdale, FL, Feb. 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Veritas Farms, Inc. (OTCQB: VFRM) (“Veritas Farms” or the “Company”), a vertically integrated agribusiness focused on the production of full spectrum hemp oil products with naturally occurring cannabinoids, is pleased to announce that Alexander Salgado, Veritas Farms’ CEO and co-founder, presented at the sixteenth annual NobleCon emerging growth investor conference held at the Seminole Hard Rock Hotel and Casino in Hollywood, Florida from February 16-18, 2020.
The annual NobleCon event is an investor-oriented conference which is focused on emerging growth companies with an objective of presenting to its target audience of small and micro/cap investors, the best possible selection of emerging growth companies. The event is also attended by Noble Capital Markets’ analysts, investment bankers, senior executives and Scientific Advisory Board members. Presenting
candidates are selected based upon an evaluation of sector relevance, market position, management composition, intellectual property, liquidity/exit strategies, potential growth opportunities and other aspects of fundamental analysis. NobleCon believes that it combines the best candidates from the emerging growth corporate world together with a targeted audience of potential investors.
Alexander Salgado, CEO and co-founder of Veritas Farms, stated, “I am very pleased to present Veritas Farms at this year’s NobleCon. Noble Capital Markets is very selective as to which companies get to present at NobleCon and I am honored that we were selected and invited to tell our story. In addition to our formal presentation, attendance at NobleCon afforded us the opportunity to explore and form many new business relationships which could potentially have positive synergy with our business model and growth plans.”
For more information on Veritas Farms, visit the Company’s website: www.theveritasfarms.com
Recent VFRM News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:21:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 09:45:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:55:12 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 08/29/2023 02:57:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 05:45:57 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM